Low density gene expression TaqMan array performed on tumor-infiltrating CD4+ lymphocytes from PyMT mice
| Gene . | P value* . | Fold† . | dCt‡ . | SD . |
|---|---|---|---|---|
| Gm-csf | <.05 | 2.0 | 8.8 | 0.83 |
| Il-13 | <.05 | 1.8 | 7.6 | 0.89 |
| Ccr6 | <.05 | −1.8 | 12.8 | 0.91 |
| Il-6 | <.05 | −2.4 | 14.2 | 0.91 |
| Csf1r | <.05 | −2.4 | 12.0 | 1.15 |
| Pu.1 | <.01 | −3.3 | 13.1 | 0.73 |
| Gene . | P value* . | Fold† . | dCt‡ . | SD . |
|---|---|---|---|---|
| Gm-csf | <.05 | 2.0 | 8.8 | 0.83 |
| Il-13 | <.05 | 1.8 | 7.6 | 0.89 |
| Ccr6 | <.05 | −1.8 | 12.8 | 0.91 |
| Il-6 | <.05 | −2.4 | 14.2 | 0.91 |
| Csf1r | <.05 | −2.4 | 12.0 | 1.15 |
| Pu.1 | <.01 | −3.3 | 13.1 | 0.73 |
The tumor-infiltrating CD4+ lymphocytes were sorted from PyMT mice reconstituted with miR-155/KD– or Ctrl LV–transduced HSPCs. N = 3 replicates, each representing a pool of 3 mice.
Shown are differentially regulated genes with P value < .05.
SD, standard deviation.
The fold change of the respective transcripts in the miR-155/KD group with respect to the control group is indicated (linear scale; “−” denotes fold-less expression in the miR-155/KD samples).
Raw expression data were normalized to Actinb (dCT).